Gilead gets
subpoena over anti-HIV drugs

Biotechnology company Gilead Sciences Inc. on Thursday announced it had received a subpoena from the U.S. Department of Justice related to its marketing and medical education programs for three of its anti-HIV medications.

Gilead issued a statement saying the subpoena requested documents for its medications Truvada, Viread, and Emtriva. Company officials said they intended to comply with the subpoena, which came from the U.S. Attorney's office in San Francisco, and cooperate in any related government investigation. (Reuters)